October 29, 2025

Discover key takeaways from HLTH 2025 including a video from Pleio CEO Michael Oleksiw. Learn how Pleio is using AI to uncover emotional barriers and empower people, not replace them, in creating a more human patient experience.

October 28, 2025

In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.

October 1, 2025

Pleio CEO Michael Oleksiw appears on Planetary Health First, Mars Next to explore how tackling loneliness is key to better health outcomes. He reveals how Pleio’s human-first approach helps patients stay on therapy by addressing emotional barriers that technology alone can’t solve.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |   SUPPLIER CONDUCT   |  CAREERS



© 2025 Pleio, Inc All rights reserved.